Incorporated in 1981, Emcure Pharmaceuticals
Ltd manufactures and markets pharmaceutical products globally
Financial Results:
Emcure Pharmaceuticals Ltd reported Revenues for Q4FY25 of ₹2,116.00 Crores up from ₹1,771.00 Crore year on year, a rise of 19.48%.
Total Expenses for Q4FY25 of ₹1,850.00 Crores up from ₹1,616.00 Crores year on year, a rise of 14.48%.
Consolidated Net Profit of ₹197.00 Crores up 62.81% from ₹121.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹9.97, up 56.76% from ₹6.36 in the same quarter of the previous year.
